Medicated Confectionery : Global Market Intelligence ( 2023-2030 )
Report Code :
SMFODN24450
Published :
07-03-2024
Pages :
70+
REPORT OBJECTIVES
The report Medicated Confectionery : Global Market Intelligence ( 2023-2030 ) provides market intelligence on the different market segments, based on Confectionery Type, Distribution Channel, Region, Company etc. Market size and forecast (2020-2030) has been provided in the report. The primary objectives of this report are to provide 1) comprehensive global market intelligence through detailed segmentation, 2) market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends, 3) detailed analysis of current dynamics and trends, key market players, and strategies in the market, 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants, 5) provide emerging opportunities in the market and the future impact of major drivers and restraints of the market and, 6) support decision makers in making cost-effective business decisions.
RESEARCH METHODOLOGY
In our market size and forecast determination efforts, an extensive secondary research was initially completed to gain a good perspective of the market in each region. Extensive primary research was also carried out by interviewing the key executives from the industry. These interviews helped us to fill-in the data gaps after secondary research. Several secondary sources such as encyclopedia, directories, and databases have been used to identify and collect information useful for this extensive techno-commercial study. The respondents – selected experts from manufacturers and selected suppliers – have been interviewed to obtain and verify critical information as well as to assess the future prospects. The usage of obtained information is based on the perceived reliability by the research team. In many cases, a combination of several sources was used. Sprout Intelligence provides an in-depth analysis of the market segmentation, which is a critical element of the market intelligence reports at Sprout Intelligence.
KEY AUDIENCE
Executives in marketing, strategic planning and new product development will find such discussions in our reports pertinent and useful. Management consultants, investment bankers, manufacturers, distributors, suppliers, and regulatory authorities are amongst our regular clientele served.
DATA SOURCES
The general data sources used in this report are company websites, trade association publications, regulatory authorities, journals, magazines, news websites, press releases, media publications, interaction with industry experts, company executives, research papers, articles, patents, scientific literature, among many others.
KEY FINDINGS FROM THE REPORT
• The Medicated Confectionery market was valued at $4,235.6 Million in 2020, and is projected to reach $5,526.9 Million by 2030 growing at a CAGR of 3.11% from 2021 to 2030.
• Chocolate segment is expected to be the highest contributor to this market, with $1,631.9 Million in 2020, and is anticipated to reach $2,034.1 Million by 2030, registering a CAGR of 2.58%.
• Gum & Mint segment is anticipated to reach $1,505.4 Million by 2030 with the highest CAGR of 4.86%.
• Chocolate and Gum & Mint segments collectively expected to account for about 61.9% share of the Medicated Confectionery market in 2020, with the former constituting around 38.5% share.
• Gum & Mint and Snack Bars segments are expected to witness significant growth rates at a CAGR of 4.86% and 3.69% respectively, during the forecast period.
• Presently, share of these two segments is estimated to be around 46.6% in the overall Medicated Confectionery market in 2020, and is anticipated to reach 51.7% by 2030.
• The global medicated confectionery market is experiencing robust growth, driven by the rising consumer demand for wellness-oriented products and a growing awareness of the health benefits associated with medicated confectionery.
• The increasing prevalence of respiratory ailments and the desire for convenient, on-the-go remedies further amplify market expansion.
• Additionally, the market is fueled by a surge in innovative product development, incorporating ingredients like menthol, eucalyptus, and herbal extracts to address specific health concerns.
• Opportunities lie in leveraging advanced manufacturing technologies to enhance product efficacy and in strategic partnerships with pharmaceutical companies to tap into broader distribution networks.
• As consumer preferences shift towards preventive healthcare, the medicated confectionery market remains well-positioned to capitalize on these trends and offer a sweet solution to health-conscious consumers globally..
1. Report Introduction
1.1. Report Description
1.1.1. Research Methodology
1.1.2. Report Objectives
1.1.3. Data Sources
1.2. Acronyms / Abbreviations
1.3. Assumptions
1.4. Limitations
2. Executive Summary
3. Medicated Confectionery Market, by Confectionery Type
3.1. Chocolate
3.2. Snack Bars
3.3. Candy & Sugar Confectionery
3.4. Gum & Mint
4. Medicated Confectionery Market, by Distribution Channel
4.1. Supermarkets
4.2. Convenience Stores
4.3. Drug Stores
4.4. Online
4.5. Other Distribution Channels
5. Medicated Confectionery Market, by Region
5.1. North America
5.1.1. US
5.1.2. Canada
5.2. Europe
5.2.3. Germany
5.2.4. U.K.
5.2.5. France
5.2.6. Italy
5.2.7. Spain
5.2.8. Rest of Europe
5.3. Asia
5.3.9. China
5.3.10. Japan
5.3.11. India
5.3.12. South Korea
5.3.13. Rest of Asia
5.4. ROW
5.4.14. Brazil
5.4.15. Mexico
5.4.16. South Africa
5.4.17. Rest of the World
6. Medicated Confectionery Market, by Company
6.1. Mondelez International
6.2. Ricola AG
6.3. Procter & Gamble
6.4. Perfetti Van Melle
6.5. Mars, Incorporated
6.6. Nestlé S.A.
6.7. Reckitt Benckiser Group plc
6.8. Lotte Confectionery Co., Ltd.
6.9. Wm. Wrigley Jr. Company
6.10. Ferrero Group
6.11. Cloetta AB
6.12. Ernest Jackson
6.13. Herbion International
6.14. Prestige Brands Holdings, Inc.
6.15. Meda Pharmaceuticals Inc.
8. Appendix
8.1. Disclaimer
8.2. About Sprout Intelligence
NA